Cleare A

Addictions Department, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

8 papers · ORCID

ArticleDMT

Psychological change processes in alcohol use disorder: A qualitative study of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) with cognitive behavioural therapy.

Seynaeve M, Dunbar F, Ermakova AO +4

Europe PMC2026
ArticlePsilocybin

Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.

Modlin NL, Williamson V, Goodwin GM +10

Europe PMC2025
ArticleKetamine

Improvements in Functioning with Esketamine Nasal Spray versus Quetiapine Extended Release in Patients with Treatment Resistant Depression

Vieta E, Ahmed N, Arango C +11

Europe PMC2025
ArticleKetamine

Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature

Ingrosso G, Cleare A, Juruena M

Europe PMC2025
ArticlePsilocybin

Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.

Modlin NL, Jessica L MK, Sarang M +6

Europe PMC2025
ArticlePsilocybin

Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.

Modlin NL, Williamson V, Maggio C +4

Europe PMC2025
ArticlePsilocybin

Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.

Modlin NL, McPhee T, Zazon N +6

Europe PMC2025
ArticlePsychedelics

A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials.

Kishon R, Modlin NL, Cycowicz YM +5

Europe PMC2024